Arkolith/Insider Trading/SKYE/Form 4

Dhillon Punit

Chief Executive Officer, DirectorSkye Bioscience, Inc. (SKYE) · full profile →Form 4 · filed Nov 19, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$414K
Net Open-Market Flow
-$414K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 18, 2024Sell(S)83K$4.99$412K330K
Nov 15, 2024Sell(S)364$5.55$2K412K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001516551-24-000116) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML